Ian Pyrah

1.2k total citations
32 papers, 847 citations indexed

About

Ian Pyrah is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ian Pyrah has authored 32 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Immunology. Recurrent topics in Ian Pyrah's work include Bone Metabolism and Diseases (8 papers), Bone health and osteoporosis research (7 papers) and Animal testing and alternatives (6 papers). Ian Pyrah is often cited by papers focused on Bone Metabolism and Diseases (8 papers), Bone health and osteoporosis research (7 papers) and Animal testing and alternatives (6 papers). Ian Pyrah collaborates with scholars based in United States, United Kingdom and Canada. Ian Pyrah's co-authors include Michael S. Ominsky, Rogely Boyce, Susan Y. Smith, Jacquelin Jolette, Joseph A. Schroeder, Paul J. Kostenuik, Efrain Pacheco, Scott L. Taylor, Kathrin Locher and Marina Stolina and has published in prestigious journals such as Cancer Research, Gut and Journal of Bone and Mineral Research.

In The Last Decade

Ian Pyrah

31 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian Pyrah United States	17	465	366	356	116	84	32	847
Susan G. Linkhart United States	13	362 0.8×	207 0.6×	243 0.7×	104 0.9×	33 0.4×	13	755
Rana Samadfam Canada	16	633 1.4×	459 1.3×	424 1.2×	186 1.6×	106 1.3×	35	1.0k
A. Markatos United States	7	554 1.2×	637 1.7×	501 1.4×	150 1.3×	110 1.3×	8	1.2k
Ying Xie China	16	492 1.1×	129 0.4×	63 0.2×	43 0.4×	88 1.0×	50	805
Jukka P. Rissanen Finland	10	225 0.5×	245 0.7×	105 0.3×	39 0.3×	52 0.6×	24	580
Motoyuki Uchida Japan	13	297 0.6×	111 0.3×	53 0.1×	156 1.3×	38 0.5×	18	658
Diane Marshall United Kingdom	13	237 0.5×	131 0.4×	46 0.1×	38 0.3×	54 0.6×	15	765
Helen Rager United States	11	110 0.2×	131 0.4×	60 0.2×	36 0.3×	38 0.5×	14	743
Naohiko Hayakawa Japan	12	221 0.5×	153 0.4×	83 0.2×	42 0.4×	54 0.6×	20	594
Marilyn Gordon Canada	13	265 0.6×	158 0.4×	147 0.4×	75 0.6×	45 0.5×	17	564

Countries citing papers authored by Ian Pyrah

Since Specialization

Citations

This map shows the geographic impact of Ian Pyrah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Pyrah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Pyrah more than expected).

Fields of papers citing papers by Ian Pyrah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Pyrah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Pyrah. The network helps show where Ian Pyrah may publish in the future.

Co-authorship network of co-authors of Ian Pyrah

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Pyrah. A scholar is included among the top collaborators of Ian Pyrah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Pyrah. Ian Pyrah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taylor, Scott L., Efrain Pacheco, Kathrin Locher, et al.. (2018). Differential time-dependent transcriptional changes in the osteoblast lineage in cortical bone associated with sclerostin antibody treatment in ovariectomized rats. Bone Reports. 8. 95–103. 17 indexed citations

Boyce, Rogely, Danielle L. Brown, Kathrin Locher, et al.. (2018). Decreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibody. Bone Reports. 8. 90–94. 24 indexed citations

Ominsky, Michael S., Steven K. Boyd, Aurore Varela, et al.. (2016). Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys. Journal of Bone and Mineral Research. 32(4). 788–801. 72 indexed citations

Chouinard, Luc, Peter Mann, Jacquelin Jolette, et al.. (2016). Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study. Regulatory Toxicology and Pharmacology. 81. 212–222. 59 indexed citations

Fielden, Mark R., Charles R. Dean, Kurt A. Black, et al.. (2016). Nonclinical Safety Profile of Etelcalcetide, a Novel Peptide Calcimimetic for the Treatment of Secondary Hyperparathyroidism. International Journal of Toxicology. 35(3). 294–308. 7 indexed citations

Taylor, Scott L., Michael S. Ominsky, Rong Hu, et al.. (2015). Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats. Bone. 84. 148–159. 77 indexed citations

Ominsky, Michael S., Danielle L. Brown, Gwyneth Van, et al.. (2015). Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats. Bone. 81. 380–391. 72 indexed citations

Boyce, Rogely, Aurore Varela, Luc Chouinard, et al.. (2014). Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period. Bone. 64. 314–325. 39 indexed citations

Bussiere, Jeanine L., Ian Pyrah, Rogely Boyce, et al.. (2013). Reproductive toxicity of denosumab in cynomolgus monkeys. Reproductive Toxicology. 42. 27–40. 29 indexed citations

10.

Andrews, Dina A., James R. Turk, Rogely Boyce, et al.. (2013). Dose-related Differences in the Pharmacodynamic and Toxicologic Response to a Novel Hyperglycosylated Analog of Recombinant Human Erythropoietin in Sprague-Dawley Rats with Similarly High Hematocrit. Toxicologic Pathology. 42(3). 524–539. 5 indexed citations

11.

Ominsky, Michael S., Brian Stouch, Joseph A. Schroeder, et al.. (2011). Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys. Bone. 49(2). 162–173. 72 indexed citations

12.

Ettlin, Robert A., Brad Bolon, Ian Pyrah, Yoichi Konishi, & Hugh E. Black. (2009). Global recognition of qualified toxicologic pathologists: Credential review as a potential route for recognizing the proficiency of pathologists involved in regulatory-type nonclinical studies. Experimental and Toxicologic Pathology. 62(4). 413–422. 4 indexed citations

13.

Ettlin, Robert A., Brad Bolon, Ian Pyrah, Yoichi Konishi, & Hugh E. Black. (2009). Global Recognition of Qualified Toxicologic Pathologists: Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical Studies. Toxicologic Pathology. 37(4). 553–561. 2 indexed citations

14.

Alférez, Denis, Robert W. Wilkinson, James Watkins, et al.. (2008). Dual inhibition of VEGFR and EGFR signaling reduces the incidence and size of intestinal adenomas in ApcMin/+ mice. Molecular Cancer Therapeutics. 7(3). 590–598. 36 indexed citations

15.

Alférez, Denis, Robert A. Goodlad, Richard Poulsom, et al.. (2006). Inhibition of VEGFR reduces polyp burden in the APC (min/+) mouse model of intestinal cancer. Gut. 210. 14–14. 1 indexed citations

16.

Ryan, Anderson J., et al.. (2004). The VEGF receptor tyrosine kinase inhibitor ZD6474 significantly reduces intestinal tumor burden in the Min mouse. Cancer Research. 64. 1075–1075. 1 indexed citations

17.

Rubinsztein, David C., Ian Pyrah, Carolyn Tysoe, et al.. (1999). Apo E genotypes and risk of dementia in Down syndrome. American Journal of Medical Genetics. 88(4). 344–347. 26 indexed citations

18.

Odum, J., Ian Pyrah, John R. Foster, et al.. (1999). Comparative Activities ofp-Nonylphenol and Diethylstilbestrol in Noble Rat Mammary Gland and Uterotrophic Assays. Regulatory Toxicology and Pharmacology. 29(2). 184–195. 38 indexed citations

19.

Odum, J., Ian Pyrah, Anthony R. Soames, et al.. (1999). Effects ofp-nonylphenol (np) and diethylstilboestrol (des) on the alderley park (alpk) rat: comparison of mammary gland and uterus sensitivity following oral gavage or implanted mini-pumps. Journal of Applied Toxicology. 19(5). 367–378. 30 indexed citations

20.

Pyrah, Ian & N.J. Watt. (1995). Immunohistological study of the cutaneous delayed type hypersensitivity reaction in sheep. Veterinary Immunology and Immunopathology. 48(3-4). 299–312. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact